Showing results (101-110 of 112) with videos related to

Sort By:
Pageof 12
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 7, 2017
Clinical Significance of Androgen Receptor Splice Variant-7 mRNA Detection in Circulating Tumor Cells of Men With Metastatic Castration-Resistant Prostate Cancer Treated With First- and Second-Line Abiraterone and EnzalutamideEmmanuel S Antonarakis, Changxue Lu, Brandon Luber, et al.
Urology|April 17, 2018
Evaluation of an Epigenetic Assay for Predicting Repeat Prostate Biopsy Outcome in African American MenRobert L Waterhouse, Leander Van Neste, Kelvin A Moses, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 14, 2024
Structural insights reveal interplay between LAG-3 homodimerization, ligand binding, and functionJohn L Silberstein, Jasper Du, Kun-Wei Chan, et al.
Oncogene|August 15, 2019
Circular RNAs add diversity to androgen receptor isoform repertoire in castration-resistant prostate cancerSubing Cao, Tianfang Ma, Nathan Ungerleider, et al.
The Lancet. Oncology|December 18, 2017
Bipolar androgen therapy in men with metastatic castration-resistant prostate cancer after progression on enzalutamide: an open-label, phase 2, multicohort studyBenjamin A Teply, Hao Wang, Brandon Luber, et al.
European Urology|September 4, 2017
Novel Junction-specific and Quantifiable In Situ Detection of AR-V7 and its Clinical Correlates in Metastatic Castration-resistant Prostate CancerYezi Zhu, Adam Sharp, Courtney M Anderson, et al.
Oncotarget|February 3, 2017
Detection fidelity of AR mutations in plasma derived cell-free DNAAlexa Goldstein, Patricia Valda Toro, Justin Lee, et al.
JCO Precision Oncology|May 28, 2019
Genetic Alterations Detected in Cell-Free DNA Are Associated With Enzalutamide and Abiraterone Resistance in Castration-Resistant Prostate CancerSamantha Torquato, Aparna Pallavajjala, Alexa Goldstein, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 14, 2019
Prospective Multicenter Validation of Androgen Receptor Splice Variant 7 and Hormone Therapy Resistance in High-Risk Castration-Resistant Prostate Cancer: The PROPHECY StudyAndrew J Armstrong, Susan Halabi, Jun Luo, et al.
Oncotarget|July 10, 2018
Ipilimumab plus nivolumab and DNA-repair defects in AR-V7-expressing metastatic prostate cancerKarim Boudadi, Daniel L Suzman, Valsamo Anagnostou, et al.
Pageof 12